Apogee rises as long-acting eczema drug heads for phase 3 Apogee's chief executive Michael Henderson.

Nektar Therapeutics has said phase 2b results show it was right to keep faith with rezpegaldesleukin as a therapy for atopic dermatitis (AD), also known as eczema. Data from the REZOLVE-AD study ...

LOS ANGELES, CA, USA I July 14, 2025 I Turn Therapeutics today announced the initiation of a randomized, double-blind, vehicle-controlled clinical trial ...

Apogee Therapeutics, Inc. (NASDAQ:APGE) is one of the 11 Hot New Stocks to Invest in Now. On July 7, analyst Edward Nash of ...

Considering dual biologic therapy for psoriasis or eczema? Get a firsthand account of navigating insurance, potential side effects, and treatment outcomes.

A small number of people using Mounjaro, Ozempic or Wegovy injections have reported increased skin sensitivity, and a number ...

Diabetes and blood pressure medications are both on the list of medications that can affect your ability to cope with the ...

Teplizumab trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average of three ...

Ashley Roberts, best known as one-fifth of the Pussycat Dolls, has revealed for the first time the details of her ...

In this video, Jeff Yu, MD, MS, emphasized the importance of chronic hand eczema awareness and highlighted a study on the causes and treatments of the disease, presented at the Revolutionizing Atopic ...

For the second time this year, Leo Pharma has struck a partnership with a major drugmaker, this time paying Boehringer ...